The experimental test was performed and examined by the leading Scientist-in-charge at CCMB, Dr. B. Kiran Kumar. It was done in duplicates and the values were averaged to calculate the percentage of viral reduction, stated the release.
I2Cure BioShield comprises only Molecular Iodine(I2) isolated at 1500 ppm(1500 parts per million) stabilized in 100% vegetable grade Glycerine. A one-time application of BioShield delivers free molecular iodine directly into the epidermis & leaves no stain or smell. This prevents it from being washed away or rubbed off. Once inside, it diffuses back to the surface of the skin & kills any viral, bacterial, and fungal load showing persistent activity for up to 6 hours.
Since BioShield is competent in breaking down the viral load at the host level, it is certainly going to limit the transmission up to a higher level. Contrary to the existing Iodine formulations that are aqueous in nature resulting in the formation of by-products that cause irritation, staining, and odour.
“We are delighted to have brought the safest, most efficacious, and skin-friendly antimicrobial that now has proven action against the SARS-CoV-2. The virus has only gotten stronger in the past few months, therefore what the nation needs is a long-term solution against all microbes and their ill effects on humankind,” said I2Cure director Ramesh Menon.
Apart from CSIR – CCMB, Analytical Lab Group (ALG), Choksi Labs, Shree Ram Testing Laboratories, and the Indian Institute of Toxicology (IIT) have all tested and certified the efficacy of Molecular Iodine against viruses, bacteria, and fungi.